CAPR Earnings Capricor Therapeutics, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–28 of 28
| Q2 2026 | 2026-06-30 | -1.29 | 2026-08-14 | 10-Q |
| Q1 2026 | 2026-03-31 | -0.59 | 2026-05-13 | 10-Q |
| FY 2025 | 2025-12-31 | -2.26 | 2026-03-17 | 10-K |
| Q3 2025 | 2025-09-30 | -1.64 | 2025-11-10 | 10-Q |
| Q2 2026 | 2025-06-30 | -1.10 | 2026-08-14 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.53 | 2026-05-13 | 10-Q |
| FY 2025 | 2024-12-31 | -1.15 | 2026-03-17 | 10-K |
| Q3 2025 | 2024-09-30 | -1.04 | 2025-11-10 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.66 | 2025-08-11 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.31 | 2025-05-14 | 10-Q |
| FY 2024 | 2023-12-31 | -0.83 | 2025-03-26 | 10-K |
| Q3 2024 | 2023-09-30 | -0.85 | 2024-11-14 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.60 | 2024-08-08 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.31 | 2024-05-14 | 10-Q |
| FY 2023 | 2022-12-31 | -1.18 | 2024-03-11 | 10-K |
| Q3 2023 | 2022-09-30 | -0.87 | 2023-11-14 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.61 | 2023-08-08 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.32 | 2023-05-12 | 10-Q |
| FY 2022 | 2021-12-31 | -0.87 | 2023-03-17 | 10-K |
| Q3 2022 | 2021-09-30 | -0.61 | 2022-11-10 | 10-Q |
| Q2 2022 | 2021-06-30 | -0.44 | 2022-08-12 | 10-Q |
| Q1 2022 | 2021-03-31 | -0.23 | 2022-05-11 | 10-Q |
| FY 2021 | 2020-12-31 | -0.88 | 2022-03-11 | 10-K |
| Q3 2021 | 2020-09-30 | -0.51 | 2021-11-12 | 10-Q |
| Q2 2021 | 2020-06-30 | -0.51 | 2021-08-13 | 10-Q |
| FY 2018 | 2018-12-31 | -0.52 | 2019-03-29 | 10-K |
| FY 2018 | 2017-12-31 | 0.09 | 2019-03-29 | 10-K |
| FY 2017 | 2016-12-31 | -1.01 | 2018-03-22 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.